Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Director dealings: PHP CEO raises stake

(Sharecast News) - Primary Health Properties revealed on Tuesday that chief executive officer Mark Davies had acquired 77,820 ordinary shares in the FTSE 250-listed real estate investment firm. Davies, who took over as CEO last year, purchased the shares on Monday at an average price of 95.90p each, for a total value of £74,629.38.

As of 1515 BST, PHP shares were down 0.52% at 95.80p.

Reporting by Iain Gilbert at Sharecast.com

Top Director Buys

Primary Health Properties (PHP) Director name: Davies,Mark Amount purchased: 77,820 @ 95.90p Value: £74,629.38

Tate & Lyle (TATE) Director name: Lestapis,Cláudia Vaz de Amount purchased: 2,500 @ $28.84 Value: $59,454.11

Inchcape (INCH) Director name: Rowley ,Stuart Amount purchased: 3,000 @ 928.97p Value: £27,868.95

First Property Group (FPO) Director name: Habib,Ben Amount purchased: 100,000 @ 15.35p Value: £15,350.00

Mercantile Investment Trust (the) (MRC) Director name: Hopkins,Heather Amount purchased: 5,162 @ 250.43p Value: £12,927.14

Synthomer (SYNT) Director name: Liu,Lily Amount purchased: 20,000 @ 63.90p Value: £12,780.00

Top Director Sells

Frontier Developments (FDEV) Director name: Braben ,David John Amount sold: 15,000 @ 373.50p Value: £56,025.00

Share this article

Related Sharecast Articles

Director dealings: Eurocell chairman raises stake
(Sharecast News) - Eurocell revealed on Thursday that non-executive chairman Derek Mapp had acquired 21,325 ordinary shares in the London-listed building products manufacturer.
Director dealings: Greatland Gold director lowers stake
(Sharecast News) - Greatland Gold revealed on Wednesday that non-executive director Alexander Borrelli had disposed of 526,880 ordinary shares in the AIM-listed gold and copper miner.
Director dealings: Genedrive CEO raises stake
(Sharecast News) - Genedrive revealed on Tuesday that chief executive Gino Miele had acquired 700,000 ordinary shares in the AIM-listed pharmacogenetic testing company.
Director dealings: Watkin Jones chairman raises shareholding
(Sharecast News) - Watkin Jones revealed on Friday that non-executive chair Alan Giddins had acquired 50,000 ordinary shares in the AIM-listed developer.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.